Genetic Variant Predicts Multiple Sclerosis Treatment Response
Study implicates new gene in multiple sclerosis disease activity A study led by researchers at Brigham and Women’s Hospital (BWH) identifies a genetic variant linked to altered response to interferon‑beta, a commonly used treatment for multiple sclerosis (MS). Published in Annals of Neurology on May 14, the report highlights SLC9A9 as a candidate gene that … Read more